NCT06762925尚未招募不适用
Study on the Efficacy and Mechanism of METTL3 Peptide Inhibitors in Enhancing Anti-tumor Immune Response by Reshaping the Tumor Microenvironment
Xijing Hospital0 个研究点目标入组 450 人开始时间: 2025年1月30日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 450
- 主要终点
- The expression levels of METTL3 and ANGPTL2
研究概览
简要总结
This study aims to validate the accuracy and clinical value of METTL3 as a biomarker for predicting immune therapy response in patients with urinary tract tumors through observational studies.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients diagnosed with urinary system tumors through pathological examination;
- •Meet specific clinical stages and surgical treatment standards;
- •Intraoperative tissue resection meets the sample testing standards;
- •The patient is willing to participate in the study and sign an informed consent form.
排除标准
- •Not meeting the specific clinical stage and not receiving surgical treatment;
- •Abnormal mental behavior;
- •Intellectual disability;
- •Age under 18 years old or over 75 years old;
- •Low understanding and communication skills.
结局指标
主要结局
The expression levels of METTL3 and ANGPTL2
时间窗: About a year and a half
次要结局
未报告次要终点
研究者
相似试验
Unknown
不适用
Analysis of Tumor Tissue and Circulating Genetic Material in the Blood to Obtain Further Insight in the Effectiveness of Everolimus When Combined With ExemestaneHormone Receptor Positive Malignant Neoplasm of BreastMetastatic Breast CancerNCT02109913Amsterdam UMC, location VUmc175
已完成
不适用
Biomarkers in Predicting Response to Chemotherapy in Samples From Young Patients With OsteosarcomaLocalized OsteosarcomaMetastatic OsteosarcomaOsteoblastic OsteosarcomaRecurrent OsteosarcomaNCT01374672Children's Oncology Group20
已完成
不适用
Methylated Genes in Blood as Biomarkers for Advanced Lung CancerLung CancerNCT00579462Memorial Sloan Kettering Cancer Center281
已完成
1 期
Evaluation and Validation of Metabolic Markers for the Assessment of CYP3A Activity and Prediction of DDIHealthyNCT02328443Seoul National University Hospital24
已完成
1 期
Identification and Evaluation of Endogenous Markers for the Assessment of CYP3A Activity Using MetabolomicsHealthyNCT01215214Seoul National University Hospital24